Morgan Stanley’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Buy |
671,044
+335,577
| +100% | +$5.02M | ﹤0.01% | 3438 |
|
|
2025
Q1 | $5.41M | Buy |
335,467
+80,211
| +31% | +$1.29M | ﹤0.01% | 3862 |
|
|
2024
Q4 | $5.94M | Buy |
255,256
+11,514
| +5% | +$268K | ﹤0.01% | 3858 |
|
|
2024
Q3 | $7.17M | Sell |
243,742
-165,111
| -40% | -$4.86M | ﹤0.01% | 3680 |
|
|
2024
Q2 | $9.61M | Buy |
408,853
+357,665
| +699% | +$8.41M | ﹤0.01% | 3353 |
|
|
2024
Q1 | $1.94M | Buy |
51,188
+51,108
| +63,885% | +$1.94M | ﹤0.01% | 4605 |
|
|
2023
Q4 | $1.72K | Buy |
80
+34
| +74% | +$732 | ﹤0.01% | 7149 |
|
|
2023
Q3 | $564 | Sell |
46
-86
| -65% | -$1.05K | ﹤0.01% | 7296 |
|
|
2023
Q2 | $1.49K | Sell |
132
-414
| -76% | -$4.67K | ﹤0.01% | 7238 |
|
|
2023
Q1 | $3.96K | Sell |
546
-2,672
| -83% | -$19.4K | ﹤0.01% | 7112 |
|
|
2022
Q4 | $36.2K | Sell |
3,218
-3,512
| -52% | -$39.5K | ﹤0.01% | 6429 |
|
|
2022
Q3 | $88K | Sell |
6,730
-5,023
| -43% | -$65.7K | ﹤0.01% | 6145 |
|
|
2022
Q2 | $148K | Buy |
11,753
+4,485
| +62% | +$56.5K | ﹤0.01% | 6049 |
|
|
2022
Q1 | $418K | Sell |
7,268
-581
| -7% | -$33.4K | ﹤0.01% | 5513 |
|
|
2021
Q4 | $932K | Buy |
7,849
+80
| +1% | +$9.5K | ﹤0.01% | 5123 |
|
|
2021
Q3 | $1.54M | Sell |
7,769
-52
| -0.7% | -$10.3K | ﹤0.01% | 4772 |
|
|
2021
Q2 | $1.36M | Buy |
7,821
+3,377
| +76% | +$588K | ﹤0.01% | 4908 |
|
|
2021
Q1 | $880K | Sell |
4,444
-680
| -13% | -$135K | ﹤0.01% | 4814 |
|
|
2020
Q4 | $1.01M | Buy |
5,124
+3,720
| +265% | +$732K | ﹤0.01% | 4664 |
|
|
2020
Q3 | $249K | Buy |
1,404
+385
| +38% | +$68.3K | ﹤0.01% | 4993 |
|
|
2020
Q2 | $235K | Buy |
1,019
+881
| +638% | +$203K | ﹤0.01% | 4999 |
|
|
2020
Q1 | $16K | Sell |
138
-1,307
| -90% | -$152K | ﹤0.01% | 5890 |
|
|
2019
Q4 | $276K | Buy |
1,445
+1,120
| +345% | +$214K | ﹤0.01% | 5266 |
|
|
2019
Q3 | $63K | Sell |
325
-1,648
| -84% | -$319K | ﹤0.01% | 5616 |
|
|
2019
Q2 | $337K | Buy |
1,973
+1,621
| +461% | +$277K | ﹤0.01% | 4794 |
|
|
2019
Q1 | $71K | Sell |
352
-727
| -67% | -$147K | ﹤0.01% | 5528 |
|
|
2018
Q4 | $202K | Sell |
1,079
-114
| -10% | -$21.3K | ﹤0.01% | 5282 |
|
|
2018
Q3 | $285K | Sell |
1,193
-419
| -26% | -$100K | ﹤0.01% | 5289 |
|
|
2018
Q2 | $427K | Buy |
1,612
+1,315
| +443% | +$348K | ﹤0.01% | 5204 |
|
|
2018
Q1 | $73K | Buy |
297
+176
| +145% | +$43.3K | ﹤0.01% | 5791 |
|
|
2017
Q4 | $16K | Hold |
121
| – | – | ﹤0.01% | 6136 |
|
|
2017
Q3 | $15K | Buy |
121
+10
| +9% | +$1.24K | ﹤0.01% | 6102 |
|
|
2017
Q2 | $11K | Buy |
111
+2
| +2% | +$198 | ﹤0.01% | 6221 |
|
|
2017
Q1 | $20K | Hold |
109
| – | – | ﹤0.01% | 6090 |
|
|
2016
Q4 | $12K | Sell |
109
-43
| -28% | -$4.73K | ﹤0.01% | 6119 |
|
|
2016
Q3 | $25K | Buy |
+152
| New | +$25K | ﹤0.01% | 5843 |
|